FEV and ProLogium develop high-performance vehicle battery
Aachen – Customer requirements for the evolution of electric cars are clearly defined: reduced weight at increased efficiency, higher range at shorter charging times and maximum safety. FEV, Germany's innovation powerhouse for the automotive and energy industry, and ProLogium, global pioneer in developing advanced vehicle batteries, fulfill precisely these requirements with their new product.

All this is made possible by LLCB technology (Large-Footprint Lithium Ceramic Battery). With its anode of 100 per cent silicon this battery offers a 10-times higher capacity density compared to graphite anodes used today. Depending on the vehicle segment and intended use, the LLCB saves up to 300 kg or allows a maximum range of 1,000 km. The applied solid-state electrolyte is non-flammable and increases safety against thermal runaway. It also prevents potential short circuits caused by leaking electrolyte fluid in the event of a spill.
“For the LLCB solution, we have successfully combined ProLogium´s know-how in the field of cell development with our development, system and testing expertise,” said Dr. Thomas Hülshorst, Global Vice President Electric Powertrain at FEV. “Our collaboration on battery packs and concept designs focuses not only on regulatory standards, but also on market requirements. We even exceed these.”
The anode also enables ultra-fast charging, charging the battery from five to 60 per cent within five minutes. This allows the user an average range of 300 km. After further three minutes, the battery is charged to 80 per cent and can cover additional 100 km. In this way, the LLCB helps to bring charging times closer to the duration of a refueling process for vehicles with combustion engines.
At the Paris Motor Show 2024, FEV and ProLogium announced to continue their joint efforts for LLCB development in the future.
Read more: https://shorturl.at/9maEg
Contacts
Marius Strasdat
T +49 241 5689-6452
strasdat@fev.com
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 12:34:15 CET | Press Release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press Release
Zoetermeer, Netherlands - 13 January 2026 - Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
ESSL leading study to find where and why damaging hail is getting worse12.1.2026 13:38:03 CET | Press Release
Wiener Neustadt, Austria jan 12, 2026 - First comprehensive global study of very large hail in a changing climate reveals contrasting trends and different causes.
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press Release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 13:27:37 CET | Press Release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom